Richard Rossman
Director/Board Member at ARCH BIOPARTNERS INC.
Net worth: 3 M $ as of 29/04/2024
Network origin in Richard Rossman first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
McMaster University
61
| College/University | Other Consumer Services | 61 |
| Public Company | Pharmaceuticals: Major | 9 | |
| Public Company | Pharmaceuticals: Major | 8 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Richard Rossman via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| University of Toronto | College/University | Graduate Degree Undergraduate Degree Doctorate Degree Graduate Degree Doctorate Degree Undergraduate Degree | |
| University of Manitoba | College/University | Undergraduate Degree Corporate Officer/Principal Director/Board Member Undergraduate Degree | |
| Queen's University | College/University | Doctorate Degree Masters Business Admin Graduate Degree | |
| BANK OF MONTREAL | Major Banks | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
| McGill University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| CAE INC. | Miscellaneous Commercial Services | Chairman Chairman Director/Board Member | |
| NORTEL NETWORKS CORPORATION (USA) | Financial Conglomerates | Director/Board Member Chairman | |
| University of Calgary | College/University | Doctorate Degree Corporate Officer/Principal | |
Order of Canada
 Order of Canada Miscellaneous Commercial ServicesCommercial Services Order of Canada is an organization based in Ottawa, Canada. The organization is affiliated with the governor general of Canada, La gouverneure générale du. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Western Ontario | College/University | Corporate Officer/Principal Graduate Degree | |
| University of Windsor | College/University | Director/Board Member Doctorate Degree | |
| TWC ENTERPRISES LIMITED | Movies/Entertainment | Director/Board Member Director/Board Member | |
| LIMINAL BIOSCIENCES INC. | Biotechnology | Director/Board Member Director/Board Member | |
| CancerCare Manitoba Foundation, Inc. | Corporate Officer/Principal Director/Board Member | ||
| York University | College/University | Undergraduate Degree Masters Business Admin | |
| University of British Columbia | College/University | Doctorate Degree Masters Business Admin | |
| WELL HEALTH TECHNOLOGIES CORP. | Medical/Nursing Services | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Memorial University of Newfoundland | College/University | Undergraduate Degree Doctorate Degree | |
BMO Nesbitt Burns, Inc.
 BMO Nesbitt Burns, Inc. Financial ConglomeratesFinance BMO Nesbitt Burns, Inc. provides investment and financial advisory services. The firm offers financial planning; estate planning and preservation; retirement, insurance, and education planning; income replacement; tax minimization; and business succession planning advisory services. The company was founded in 1912 and is headquartered in Toronto, Canada. | Financial Conglomerates | Corporate Officer/Principal Director/Board Member | |
| MBMI RES INC | Other Metals/Minerals | Director/Board Member Chairman | |
| Canada Foundation For Innovation | Investment Trusts/Mutual Funds | Chairman Corporate Officer/Principal | |
Humber River Health
 Humber River Health Hospital/Nursing ManagementHealth Services Humber River Health is a community hospital that values accountability and transparency in their healthcare services. The private company is based in Toronto, Canada, and has subsidiaries in Canada. The Canadian company believes in keeping their patients informed about their operations and services. | Hospital/Nursing Management | Chairman Chairman | |
Chartered Professional Accountants of Ontario
 Chartered Professional Accountants of Ontario Miscellaneous Commercial ServicesCommercial Services Chartered Professional Accountants of Ontario engages in the provision of accounting education. It offers certification, continued trainings, and professional development. The company was founded in 2014 and is headquartered in Toronto, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Ottawa | College/University | Graduate Degree Graduate Degree | |
MaRS Discovery District
 MaRS Discovery District Miscellaneous Commercial ServicesCommercial Services MaRS Discovery District owns and operates a convergence center. It offers business research, information technology; pharmaceutical, optical sciences advisory and start up business assistance services. The company was founded in 2000 and is headquartered in Toronto, Canada. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| CANADIAN IMPERIAL BANK OF COMMERCE | Regional Banks | Chairman Director/Board Member | |
| CIRCIO HOLDING ASA | Biotechnology | Chairman | |
Essential Pharmaceuticals Ltd.
 Essential Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Essential Pharmaceuticals Ltd. manufactures pharmaceutical products. The company was founded on November 24, 2010 and is headquartered in Egham, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
| Gyrus Capital SA | Investment Managers | Private Equity Investor | |
BiognoSYS AG
 BiognoSYS AG Packaged SoftwareTechnology Services BiognoSYS AG operates as a biotechnology company. Its products include iRT Kit, HRM Kit, Sample Prep Kit, PlasmaDive, Spectronaut and SpectroDive. The company was founded by Philipp M. Antoni, Johan Malmstroem and Oliver Rinner on September 3, 2008 and is headquartered in Schlieren, Switzerland. | Packaged Software | Chairman | |
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Targovax Oy
 Targovax Oy Pharmaceuticals: MajorHealth Technology Targovax Oy focuses on the development and commercialization of targeted cancer immunotherapy. It is a biotechnology company with novel immunotherapy platform that is based on engineered oncolytic viruses armed with potent immune-stimulating transgenes. The firm's products induce a tailored response by the immune system directed at each patient’s unique cancer cells. The company was founded by Pekka Ilmari Simula and Antti Vuolanto in 2009 and is headquartered in Helsinki, Finland. | Pharmaceuticals: Major | Chairman | |
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
Canadian Public Accountability Board
 Canadian Public Accountability Board Miscellaneous Commercial ServicesCommercial Services Canadian Public Accountability Board operates as an audit regulator. The company was founded in 2003 and is headquartered in Toronto, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
PIQUR Therapeutics AG
 PIQUR Therapeutics AG Pharmaceuticals: OtherHealth Technology PIQUR Therapeutics AG engages in development of anti-cancer drugs based on the inhibition. Its products include PQR309, PQR620 and PQR5xx. The company was founded by Bernd Giese, Vladimir Cmiljanovic, Andreas Emmenegger, Ralf Rosenow and Matthias Wymann in August 2011 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Other | Chairman | |
| SANTHERA PHARMACEUTICALS HOLDING AG | Pharmaceuticals: Major | Director/Board Member | |
| SQZ BIOTECHNOLOGIES COMPANY | Biotechnology | Director/Board Member | |
NMD Pharma A/S
 NMD Pharma A/S BiotechnologyHealth Technology NMD Pharma ApS engages with the research and preparation of small molecules targeting an undisclosed ion. It offers medical treatment of neuromuscular diseases for patients with chronic muscle wasting diseases such as myasthenia gravis and amyotrophic lateral sclerosis. The company was founded by Ole B?kgaard Nielsen, Thomas Holm Pedersen, and Claus Elsborg Olesen on May 7, 2015 and is headquartered in Aarhus, Denmark. | Biotechnology | Chairman | |
| ADVANZ PHARMA CORP. LIMITED | Pharmaceuticals: Major | Director/Board Member | |
Micreos BV
 Micreos BV Pharmaceuticals: GenericHealth Technology Micreos BV develops phage-based products against specific dangerous bacteria. It offers human health, food safety, agriculture and animal health products. The company was founded by Mark Offerhaus and is headquartered in Wageningen, the Netherlands. | Pharmaceuticals: Generic | Chairman | |
| PharmaDerm Laboratories Ltd. | President | ||
| ACACIA PHARMA GROUP PLC | Pharmaceuticals: Other | Chairman | |
Acacia Pharma Ltd.
 Acacia Pharma Ltd. Pharmaceuticals: MajorHealth Technology Acacia Pharma Ltd. develops supportive care product opportunities for post-surgical and cancer patients. It specializes in the discovery and development of cancer supportive care product opportunities based on established drugs. The firm’s product pipeline addresses supportive care indications, such as post-operative and chemotherapy-induced nausea and vomiting, xerostomia and cachexia. The company was founded by Andrew Muncey, Julian Clive Gilbert and Robert William Gristwood in 2006 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
| SPERO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| INHIBIKASE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Alzheimer Society of Toronto | Corporate Officer/Principal | ||
| AMRYT PHARMA PLC | Pharmaceuticals: Major | Director/Board Member | |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investment Managers | Private Equity Investor | |
| DeGroote School of Business | College/University | Corporate Officer/Principal |
Statistics
International
| Canada | 31 |
| United Kingdom | 8 |
| United States | 5 |
| Switzerland | 5 |
| Netherlands | 3 |
Sectoral
| Health Technology | 18 |
| Consumer Services | 14 |
| Finance | 7 |
| Commercial Services | 6 |
| Health Services | 3 |
Operational
| Director/Board Member | 251 |
| Corporate Officer/Principal | 123 |
| Chairman | 72 |
| Independent Dir/Board Member | 52 |
| Chief Executive Officer | 43 |
Most connected contacts
| Insiders | |
|---|---|
| Grant B. Walsh | 30 |
| Patrick Volkert Vink | 30 |
| John Manley | 28 |
| Terrance Owen | 26 |
| Emõke J. E. Szathmáry | 26 |
| Ken Cawkell | 24 |
| Kevin P. D. Smith | 20 |
| Paul D. Campbell | 18 |
| Fraser Reeve Berrill | 17 |
| Connie A. Stefankiewicz | 16 |
| Adrian Haigh | 15 |
| Michael Verbora | 14 |
| Jacob M. Kay | 14 |
| Marc Kealey | 14 |
| Gary Kain | 12 |
- Stock Market
- Insiders
- Richard Rossman
- Company connections
